Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-08-01 / J. Cell. Mol. Med. 2012 Aug;16(8):1776-91Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2012-08-01 / Cancer Cell Int. 2012 Aug;12(1):35Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery
/in Colorectal Cancer, Hyperthermia, International Publications /von 2012-07-31 / Br J Anaesth 2012 Nov;109(5):754-61Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2012-07-27 / Int J Hyperthermia 2012;28(7):597-604Cell-type-specific innate immune response to oncolytic Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2012-07-18 / Viral Immunol. 2012 Aug;25(4):268-76Successful treatment of solitary bone metastasis of non-small cell lung cancer with bevacizumab and hyperthermia
/in Hyperthermia, International Publications, NSCLC /von 2012-07-03 / Pathol. Oncol. Res. 2013 Jan;19(1):119-22Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation
/in Dendritic Cells, International Publications /von 2012-07-01 / Immunotherapy 2012 Jul;4(7):703-18Recent clinical experience with oncolytic viruses
/in International Publications, Newcastle Disease Virus /von 2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1834-41Bugs and drugs: oncolytic virotherapy in combination with chemotherapy
/in International Publications, Newcastle Disease Virus /von 2012-07-01 / Curr Pharm Biotechnol 2012 Jul;13(9):1817-33Immunotherapies for non-small-cell lung cancer and mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-06-28 / Lancet Oncol. 2012 Jul;13(7):e301-10Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study
/in Cervical Cancer, Hyperthermia, International Publications /von 2012-06-12 / Int J Hyperthermia 2012;28(6):554-61Old and new facts about hyperthermia-induced modulations of the immune system
/in Hyperthermia, International Publications /von 2012-06-12 / Int J Hyperthermia 2012;28(6):528-42Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)Autologous dendritic cell vaccine (ADCV) in combination with plasmapheresis (PP) and cyclophosphamide (Cy) in patients with disseminated melanoma: A phase II study.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr e13059)WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with glioblastoma.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2084)Correlation of survival with tumor antigen expression in patients with newly diagnosed glioblastoma receiving a multi-epitope pulsed dendritic cell vaccine.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2087)CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2525)Adjuvant dendritic cell (DC)-based vaccine therapy of melanoma patients.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2524)Dendritic/tumor fusion cells as cancer vaccines
/in Dendritic Cells, International Publications /von 2012-06-01 / Semin. Oncol. 2012 Jun;39(3):287-95